Prevention trials in Alzheimer's disease: Design issues

被引：0
|
作者：
Thal, L [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80310-5
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] Statistical issues in prevention and therapeutic trials of Alzheimer disease
    Brookmeyer, R
    Zeger, S
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 : 27 - 30
  • [2] SECONDARY PREVENTION TRIALS IN PRECLINICAL ALZHEIMER'S DISEASE
    Sperling, Reisa
    NEUROBIOLOGY OF AGING, 2016, 39 : S16 - S16
  • [3] Clinical trials in Alzheimer's disease: a congress of prevention
    Ousset, P. J.
    CAHIERS DE L ANNEE GERONTOLOGIQUE, 2010, 2 (01): : 67 - 67
  • [4] Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
    Michael S. Rafii
    CNS Drugs, 2020, 34 : 785 - 794
  • [5] Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
    Rafii, Michael S.
    CNS DRUGS, 2020, 34 (08) : 785 - 794
  • [6] Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
    Carrillo, Maria C.
    Brashear, H. Robert
    Logovinsky, Veronika
    Ryan, J. Michael
    Feldman, Howard H.
    Siemers, Eric R.
    Abushakra, Susan
    Hartley, Dean M.
    Petersen, Ronald C.
    Khachaturian, Ara S.
    Sperling, Reisa A.
    ALZHEIMERS & DEMENTIA, 2013, 9 (02) : 123 - 131
  • [7] Ethical Issues in Clinical Drug Trials in Alzheimer's Disease
    Cleland, Elizabeth G.
    Snellgrove, Carol A.
    Hecker, Jane R.
    AUSTRALASIAN JOURNAL ON AGEING, 2001, 20 (03) : 112 - 113
  • [8] Methodological issues in estrogen treatment trials for Alzheimer's disease
    Mulnard, RA
    FUTURE OF HORMONE THERAPY: WHAT BASIC SCIENCE AND CLINICAL STUDIES TEACH US, 2005, 1052 : 173 - 181
  • [9] The Alzheimer's disease centers' neuropsychological database initiative: A resource for Alzheimer's disease prevention trials
    Grundman, M
    Kim, HT
    Salmon, D
    Storandt, M
    Smith, G
    Ferris, S
    Mohs, R
    Brandt, J
    Doody, R
    Welsh-Bohmer, K
    Saxton, J
    Saine, K
    Schmitt, F
    Ogrocki, P
    Johnson, N
    Howieson, D
    Papka, M
    Green, J
    Gamst, A
    Kukull, W
    Thal, LJ
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 129 - 140
  • [10] Design and sample size considerations for Alzheimer's disease prevention trials using multistate models
    Brookmeyer, Ron
    Abdalla, Nada
    CLINICAL TRIALS, 2019, 16 (02) : 111 - 119
12345